Leif Wide

Q: What Schools Are Affiliated With Leif Wide

Leif Wide is affiliated with the following schools: Norwegian University of Science and Technology, Uppsala University

Leif Wide's AcademicInfluence.com Rankings

Leif Wide

Computer Science

#3320

World Rank

#3483

Historical Rank

Computational Linguistics

#146

World Rank

#150

Historical Rank

Machine Learning

#361

World Rank

#366

Historical Rank

Artificial Intelligence

#554

World Rank

#565

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Leif Wide Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Leif Wide's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diagnosis of allergy by an in-vitro test for allergen antibodies. (1967) (1160)
Radioimmunoassay of proteins with the use of Sephadex-coupled antibodies (1966) (580)
Malignant Carcinoid Tumors An Analysis of 103 Patients with Regard to Tumor Localization, Hormone Production, and Survival (1987) (283)
Radioimmunoassays employing immunosorbents. (1969) (267)
Radioimmunoassay of 2 -microglobulin in human biological fluids. (1971) (260)
A new class of immunoglobulin in human serum. (1968) (255)
Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. (1991) (223)
Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. (1992) (211)
An immunological pregnancy test. (1960) (201)
Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results. (1986) (174)
The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women (1994) (173)
Radioimmunosorbent assay for proteins. Chemical couplings of antibodies to insoluble dextran (1967) (163)
Medical treatment and long‐term survival in a prospective study of 84 patients with endocrine pancreatic tumors (1990) (163)
Clinical significance of specific IgE to common allergens (1971) (160)
Circadian rhythm of erythropoietin in human serum (1989) (157)
Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue--a new approach to birth control? (1978) (155)
Hypocalcemia and parathyroid hormone secretion in critically ill patients (2000) (154)
Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein‐lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapy (1981) (140)
Serum ferritin during infection. A longitudinal study. (2009) (138)
Hypersensitive reactions and antibody formation during L‐asparaginase treatment of children and adults with acute leukemia (1976) (137)
Neuroendrocine pancreatic tumours: clinical presentation, biochemical and histopathological findings in 84 patients (1990) (131)
INTRANASAL GONADOTROPIN-RELEASING HORMONE AGONIST AS A CONTRACEPTIVE AGENT (1979) (130)
Detection in blood and urine of recombinant erythropoietin administered to healthy men. (1995) (127)
VARIATION IN LH AND FSH RESPONSE TO LH‐RELEASING HORMONE DURING THE MENSTRUAL CYCLE (1972) (125)
Radioimmunosorbent assay of follicle-stimulating hormone and luteinizing hormone in serum and urine from men and women. (1973) (124)
Inhibitory effects on gonadotrophin secretion and gonadal function in men during chronic treatment with a potent stimulatory luteinizing hormone-releasing hormone analogue. (1979) (121)
Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity. (1989) (118)
Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids. (1996) (116)
Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumours (1978) (115)
Ultrasonographical and hormonal description of the normal ovulatory menstrual cycle (1994) (114)
TREATMENT OF MALIGNANT ENDOCRINE PANCREATIC TUMOURS WITH HUMAN LEUCOCYTE INTERFERON (1986) (113)
Diabetes mellitus, glucose tolerance and insulin response to glucose in patients with primary hyperparathyroidism before and after parathyroidectomy (1983) (105)
Testosterone as a biological marker in psychopathy and alcoholism (1998) (104)
Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. (1989) (102)
Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance--a prospective randomized double-blind study. (2009) (101)
Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanism other than anaemia for stimulation (1989) (99)
Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function. (2001) (95)
A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience. (1987) (95)
Reaginic antibody (IgE), skin, and provocation tests to Dermatophagoides culinae and house dust in respiratory allergy. (1969) (93)
Molecular charge heterogeneity of human serum erythropoietin (1990) (92)
Median charge and charge heterogeneity of human pituitary FSH, LH and TSH. II. Relationship to sex and age. (1985) (90)
An immunological method for the assay of human chorionic gonadotrophin. (1962) (89)
Cytotoxic treatment in patients with malignant carcinoid tumors. Response to streptozocin--alone or in combination with 5-FU. (1987) (89)
The regulation of metabolic clearance rate of human FSH in mice by variation of the molecular structure of the hormone. (1986) (86)
Male and female forms of human follicle-stimulating hormone in serum. (1982) (86)
Detection of penicillin allergy of the immediate type by radioimmunoassay of reagins (IgE) to penicilloyl conjugates (1971) (84)
Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones. (1987) (82)
Successful induction of follicular maturation and ovulation by prolonged treatment with LH-releasing hormone in women with anorexia nervosa. (1975) (82)
Inhibition of ovulation in women by intranasal treatment with a luteinizing hormone-releasing hormone agonist. (1979) (76)
Reduction of blood pressure by treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance. (2009) (76)
hCG and hCG subunits as tumour markers in patients with endocrine pancreatic tumours and carcinoids. (1981) (76)
Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism (1991) (76)
Short‐term intermittent normobaric hypoxia‐haematological, physiological and mental effects (1998) (75)
Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer (1999) (75)
Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment (1992) (74)
Median charge and charge heterogeneity of human pituitary FSH, LH and TSH. I. Zone electrophoresis in agarose suspension. (1985) (72)
Treatment of myelodysplastic syndromes with recombinant human erythropoietin (1991) (71)
FSH, LH, TeBG-capacity, estrogen and progesterone in women with premenstrual tension during the luteal phase. (1976) (71)
Correlates of pregnancy oestrogen, progesterone and sex hormone-binding globulin in the USA and China (2002) (68)
Evaluation of the prognosis of threatened abortion from the peripheral plasma levels of progesterone, estradiol, and human chorionic gonadotropin. (1973) (68)
Reduced gonadotropin secretion in postmenopausal women during treatment with a stimulatory LRH analogue. (1979) (67)
INDUCTION OF A MIDCYCLE‐LIKE PEAK OF LUTEINIZING HORMONE IN YOUNG WOMEN BY EXOGENOUS OESTRADIOL‐17β (1971) (66)
Serum half-life of pituitary gonadotropins is decreased by sulfonation and increased by sialylation in women. (2009) (66)
Relationships Between Calcium Metabolic Indices and Blood Pressure in Patients with Essential Hypertension as Compared with a Healthy Population (1987) (66)
The invasive pituitary adenoma. A prolactin-producing tumor. (1977) (65)
Clinical patterns and results of radioallergosorbent test (RAST) and skin tests in penicillin allergy (1976) (65)
Qualitative difference in follicle-stimulating hormone activity in the pituitaries of young women compared to that of men and elderly women. (1983) (65)
Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department (1997) (65)
Hypothyroidism due to thyroid-hormone-binding antibodies. (1977) (64)
Chronic pulsatile low dose GnRH therapy for induction of testosterone production and spermatogenesis in a man with secondary hypogonadotropic hypogonadism. (1982) (63)
Luteinizing hormone (LH) and progesterone in plasma and LH and oestrogens in urine during 42 normal menstrual cycles. (1971) (62)
A radiosorbent technique for the assay of serum vitamin B12. (1971) (62)
Periovulatory levels of plasma progesterone and luteinizing hormone in women. (1969) (62)
Hypertension in primary hyperparathyroidism--reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study. (1988) (60)
Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer--a population-based case-control study. (1993) (60)
Increased bone turnover during gonadotropin-releasing hormone superagonist-induced ovulation inhibition. (1987) (60)
Defective regulation of the cytosolic Ca2+ activity in parathyroid cells from patients with hyperparathyroidism (1984) (58)
THE LH‐RELEASING HORMONE TEST IN 31 WOMEN WITH SECONDARY AMENORRHOEA (1972) (58)
Marked gender differences in ambulatory morning growth hormone values in young adults. (1998) (57)
Clinical significance of measurement of reaginic (IgE) antibody by Rast (1973) (57)
Effects of Thyrotrophin‐Releasing Hormone on Plasma Levels of TSH, FSH, LH and GH in Anorexia Nervosa (1972) (56)
Higher plasma disappearance rate in the mouse for pituitary follicle-stimulating hormone of young women compared to that of men and elderly women. (1984) (54)
Serum levels of TSH, T3, rT3, T4 and T3-resin uptake in surgical trauma. (1978) (54)
Immunological aspects of respiratory allergy in budgerigar (Melopsittacus undulatus) fanciers (1971) (54)
Impaired glucose handling in active rheumatoid arthritis: effects of corticosteroids and antirheumatic treatment. (1987) (53)
Influence of the assay method used on the selection of the most active forms of FSH from the human pituitary. (1986) (52)
Glucose and lipoprotein metabolism in primary hyperparathyroidism. Effects of parathyroidectomy. (1978) (51)
IMMUNOLOGICAL DETERMINATION OF HUMAN PITUITARY LUTEINIZING HORMONE (LH) (1961) (51)
Peptide hormone markers in screening for endocrine tumors in multiple endocrine adenomatosis type I. (1982) (50)
Increase in serum parathyroid hormone levels after prolonged physical exercise. (1988) (50)
Diagnosis of hypersensitivity to dog epithelium in patients with asthma bronchiale. (1970) (50)
Gonadotrophin-releasing hormone treatment for induction of follicular maturation and ovulation in amenorrhoeic women with anorexia nervosa. (1975) (49)
Early diagnosis of pregnancy. (1969) (49)
Long-term intranasal luteinizing hormone-releasing hormone agonist treatment for contraception in women. (1982) (48)
Effects of high intake of dietary animal protein on mineral metabolism and urinary supersaturation of calcium oxalate in renal stone formers. (1984) (47)
Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men. (2007) (47)
PROLONGED LOW‐INTENSITY EXERCISE RAISES THE SERUM PARATHYROID HORMONE LEVELS (1986) (46)
Plasma testosterone, LH and FSH during the first 24 hours after surgical operations. (1973) (46)
Regulation of parathyroid hormone release in primary and secondary hyperparathyroidism - studies in vivo and in vitro. (1982) (45)
Immunological determination of pituitary luteinizing hormone in the urine of fertile and post-menopausal women and adult men. (1962) (45)
Serum prolactin in patients with hypothalamus and pituitary disorders. (1981) (45)
Effects of prolonged adrenaline infusion and of mental stress on plasma minerals and parathyroid hormone. (1990) (44)
Immunologic Determination of Human Chorionic Gonadotrophin in Serum (1963) (44)
Pulsatile low dose luteinizing hormone-releasing hormone treatment for induction of follicular maturation and ovulation in women with amenorrhoea. (1982) (44)
Luteolysis induced by a luteinizing hormone-releasing hormone agonist is prevented by human chorionic gonadotropin. (1980) (43)
Human pituitary luteinizing hormone. Isolation and characterization of four glycoproteins with luteinizing activity. (1975) (43)
Intact serum parathyroid hormone levels increase during running exercise in well-trained men (1994) (43)
Hypersecretion of an abnormal form of follicle-stimulating hormone associated with suppressed luteinizing hormone secretion in a woman with a pituitary adenoma. (1981) (42)
Mental wellbeing and quality of sexual life in women with primary Sjögren’s syndrome are related to circulating dehydroepiandrosterone sulphate (2003) (42)
CV 205‐502: A NEW LONG‐ACTING DRUG FOR INHIBITION OF PROLACTIN HYPERSECRETION (1987) (42)
Patterns of depression reflected in pituitary - thyroid and pituitary - adrenal endocrine changes (1982) (42)
Serum Ferritin Levels in Male Blood Donors (1978) (42)
Disturbance of basal and stimulated serum levels of intact parathyroid hormone in primary hyperparathyroidism. (1991) (41)
Human pituitary prolactin: isolation and characterization of three isohormones with different bioassay and radioimmunoassay activities. (1980) (41)
Endometrial patterns in women on chronic luteinizing hormone-releasing hormone agonist treatment for contraception. (1981) (41)
The postoperative decrease of plasma testosterone in man, after major surgery, in relation to plasma FSH and LH. (1973) (41)
Isolation of five active thyrotropin components from human pituitary gland. (1975) (41)
Dynamic changes in glycosylation and glycan composition of serum FSH and LH during natural ovarian stimulation (2013) (40)
Failure to induce early abortion by huge doses of a superactive LRH agonist in women. (1982) (40)
4.4. Quality requirements of basal S-TSH assays in predicting an S-TSH response to TRH (1980) (40)
Stimulation of parathyroid hormone secretion by EDTA infusion--a test for the differential diagnosis of hypercalcaemia. (1986) (39)
Optimal discrimination of mild hyperparathyroidism with total serum calcium, ionized calcium and parathyroid hormone measurements. (1987) (38)
Cytosolic free calcium in platelets: relationships to blood pressure and indices of systemic calcium metabolism. (1988) (38)
Regression of a prolactin-secreting pituitary tumor during long-term treatment with bromocriptine. (1978) (38)
Serum gastrin determination with a radioimmunosorbent technique. (1977) (38)
Pulsatile subcutaneous low-dose gonadotropin-releasing hormone treatment of anovulatory infertility. (1983) (37)
Some qualitative differences of hCG in serum from early and late pregnancies and trophoblastic diseases. (1987) (37)
Inhibition of the positive feedback of oestradiol during treatment with subcutaneous implants of d-norgestrel. (1976) (37)
Erythropoietin concentrations during 10 days of normobaric hypoxia under controlled environmental circumstances. (2002) (37)
Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea. (1978) (37)
Prostaglandin release from the human umbilical artery in vitro. (1973) (37)
Isolation of human pituitary prolactin. (1979) (36)
Bromocriptine treatment of prolactinomas. (1979) (36)
Antibody reactivity in penicillin-sensitive patients determinated with different penicillin derivatives. (1977) (35)
Serum levels of thyroid hormones as biological markers in a Swedish forensic psychiatric population (1998) (35)
Alteration in density, morphology and parathyroid hormone release of dispersed parathyroid cells from patients with hyperparathyroidism. (2009) (35)
Thyroid disease and function in breast cancer patients and non-hospitalized controls evaluated by determination of TSH, T3, rT3 and T4 levels in serum. (1978) (34)
Gender differences in diurnal growth hormone and epinephrine values in young adults during ambulation. (1999) (34)
Change in electrophoretic mobility of human follicle-stimulating hormone in serum after administration of gonadotropin-releasing hormone. (1990) (34)
The effects of octreotide on basal and stimulated hormone levels in patients with carcinoid syndrome. (1989) (34)
Serum ferritin in alcoholics and the relation to liver damage, iron state and erythropoietic activity. (2009) (34)
Increased urinary clearance for albumin, 2 -microglobulin, insulin and luteinizing hormone following surgical or accidental trauma. (1972) (34)
Effects of progesterone on the serum levels of FSH and LH in postmenopausal women treated with oestrogen. (1971) (34)
MENSTRUAL FUNCTION AND SERUM PROLACTIN LEVELS AFTER LONG‐TERM BROMOCRIPTINE TREATMENT OF HYPERPROLACTINAEMIC AMENORRHOEA (1982) (33)
Chromatographic studies on a chorionic gonadotropic activity in the placenta of the rat, mouse and hamster. (1978) (33)
A change in the isoforms of human chorionic gonadotropin occurs around the 13th week of gestation. (1994) (33)
Clinical correlations between long‐term (IgE) and short‐term (IgG S‐TS) anaphylactic antibodies in atopic and ‘non‐atopic’ subjects with respiratory allergic disease (1979) (33)
Effects of continuous daily administration of 0.5 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogens. (1970) (33)
Serum ferritin and erythrocyte 2,3-DPG during quantitated phlebotomy and iron treatment. (2009) (32)
INTRANASAL LHRH AGONIST TREATMENT FOR INHIBITION OF OVULATION IN WOMEN: CLINICAL ASPECTS (1982) (32)
A fast and sensitive radioimmunoassay of human myoglobin for use in the early diagnosis of heart infarction. (1980) (31)
IgE—antibodies and skin test reactions to a detergent—enzyme in Swedish consumers (1974) (31)
Treatment of malignant endocrine pancreatic tumors with human leukocyte interferon. (1987) (30)
Pituitary and ovarian function in women on continuous low dose progestogens; effect of chlormadinone acetate and norethisterone. (1969) (30)
Human gonadotropin therapy. II. Serum estradiol and progesterone patterns during nonconceptual cycles. (1983) (29)
The common genetic variant of luteinizing hormone has a longer serum half-life than the wild type in heterozygous women. (2010) (29)
Chorionic gonadotrophin in the mouse from implantation to term. (1979) (29)
An international collaborative study of 69-104, a reference preparation of human pituitary FSH and LH. (1973) (29)
Response of anaemia in rheumatoid arthritis to treatment with subcutaneous recombinant human erythropoietin. (1992) (29)
Estradiol receptor activity in uteri of pregnant mice given lead before implantation. (1980) (28)
Prolactin secretion and menstrual function after long-term bromocriptine treatment. (1987) (28)
BROMOCRIPTINE‐INDUCED PREGNANCIES IN WOMEN WITH LARGE PROLACTINOMAS (1982) (28)
Effects of epinephrine and norepinephrine on serum parathyroid hormone and calcium in normal subjects. (2009) (28)
Testosterone, luteinizing hormone and growth hormone in blood following surgical trauma. (1972) (27)
Return of menstruation and normalization of prolactin in hyperprolactinemic women with bromocriptine-induced pregnancy. (1985) (27)
Effects of blood transfusions on some hematological variables in endurance athletes. (1989) (27)
Follicle stimulating hormone (FSH) and interstitial cell stimulating hormone (ICSH) in relation to gametic output in 643 males. (1973) (27)
Clinical significance of total IgE and of specific IgE to Dermatophagoides spp., grass pollen and other common allergens II. Relationship to clinical manifestations (1972) (26)
Detergent Enzymes and Occupational Safety (1981) (26)
THE SITE OF PROGESTERONE PRODUCTION IN EARLY PREGNANCY (1971) (26)
Evidence for diverse structural variations of the forms of human FSH within and between pituitaries. (1987) (26)
Amplitude regulation of episodic release, in vitro biological to immunological ratio, and median charge of human chorionic gonadotropin in pregnancy. (1994) (26)
Effects of a luteinizing hormone-releasing hormone agonist on luteal function in women. (1980) (26)
Glucose tolerance and insulin response during daily continuous low-dose oral contraceptive treatment. (1969) (25)
Detection of circulating IgG aggregates and immune complexes using 125I protein A from Staphylococcus aureus. (1976) (25)
Early follicular phase luteinizing hormone-releasing hormone agonist administration - effects on follicular maturation and corpus luteum function in women. (1982) (25)
Characterization of dimeric forms of human pituitary growth hormone by bioassay, radioreceptor assay, and radioimmunoassay. (1990) (25)
Effects of short‐term administration of growth hormone in healthy young men, women, and women taking oral contraceptives (2000) (25)
Metabolic cardiovascular risk factors and the renin-aldosterone system in essential hypertension. (1992) (24)
Endocrine Changes Before and After the Menarche (1973) (24)
STUDIES OF THYROID HORMONE AND METHIMAZOLE LEVELS IN PATIENTS WITH GRAVES' DISEASE ON A STANDARDIZED ANTI‐THYROID DRUG REGIMEN (1981) (24)
Treatment of the Carcinoid Syndrome with SMS 201-995, a Somatostatin Analogue (1986) (24)
SERUM PROLACTIN AND GONADOTROPHIN LEVELS BEFORE AND AFTER LUTEINIZING HORMONE‐RELEASING HORMONE IN THE INVESTIGATION OF AMENORRHOEA (1978) (24)
Metabolic clearance of human chorionic gonadotrophin administered to non pregnant women. (1968) (24)
Sexual function in males with pituitary tumors. (1978) (23)
The importance of human chorionic gonadotropin support of the corpus luteum during human gonadotropin therapy in women with anovulatory infertility. (1988) (23)
Pulsatile GnRH therapy--an alternative successful therapy for induction of ovulation in infertile normo- and hyperprolactinaemic amenorrhoeic women with pituitary tumours. (1985) (23)
Prolactin levels in the insulin tolerance test with and without pre-treatment with dexamethasone. (1977) (22)
Ethnic Differences in Breast Cancer Risk: A Possible Role for Pregnancy Levels of Alpha-Fetoprotein? (2003) (22)
Allergens and antigens of Dermatophagoides farinae. (1970) (22)
A solid phase radioimmunoassay method for ferritin in serum using (125)I-labelled ferritin. (1977) (22)
MEDICAL PROBLEMS IN THE DETERGENT INDUSTRY CAUSED BY PROTEOLYTIC ENZYMES FROM BACILLUS SUBTILIS (1972) (22)
Human gonadotropin therapy. II. Serum estradiol and progesterone patterns during nonconceptual cycles**Supported by grant 13X-3145 from the Swedish Medical Research Council. (1983) (22)
Differentiated reticuloendothelial system (res) function in some critical surgical conditions. (1974) (22)
Hyperprolactinaemia in amenorrhoea - incidence and clinical significance. (1977) (22)
Preoperative serum levels of follicle stimulating hormone (FSH) and prognosis in invasive breast cancer. (2004) (22)
Effects of tricyclic antidepressants on human plasma levels of TSH, GH and prolactin (1978) (21)
Regional and systemic effects of short‐term intense muscular work on plasma concentration and content of total and ionized calcium (1985) (21)
The dual action of glucose on the cytosolic Ca2+ activity in pancreatic beta-cells. Demonstration of an inhibitory effect of glucose on insulin release in the mouse and man. (1985) (21)
Thyrotropin-releasing hormone testing during antithyroid drug treatment of Graves' disease as an indicator of remission. (1985) (21)
Ovarian function during use of subdermal implants releasing low doses of levonorgestrel. (1990) (21)
SCREENING FOR MULTIPLE ENDOCRINE NEOPLASIA SYNDROME (TYPE 1) IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM (1984) (21)
Circulating ionized calcium and parathyroid hormone levels following coronary artery by-pass surgery. (1999) (20)
Relationship between the sex of the foetus and the amount of human chorionic gonadotrophin in placentae from the 10th to the 20th week of pregnancy. (1974) (20)
Hyperprolactinaemic amenorrhoea--results of treatment with bromocriptine. (1978) (20)
Pre-operative oestradiol levels - relation to survival in breast cancer. (2001) (20)
Effects of bromocriptine-induced pregnancy on prolactin-secreting pituitary tumours. (1981) (20)
Chorionic gonadotrophin in the human placenta in relation to the sex of the foetus at term. (1974) (19)
Low-glycosylated forms of both FSH and LH play major roles in the natural ovarian stimulation (2018) (19)
IMPAIRED SECRETION OF PARATHYROID HORMONE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RELATIONSHIP TO INFLAMMATORY ACTIVITY (1990) (19)
Suppression of serum parathyroid hormone levels by intravenous alphacalcidol in uremic patients on maintenance hemodialysis. A pilot study. (1988) (19)
Serum ferritin during inflammation. A study on myocardial infarction. (2009) (19)
Electrophoretic and gel chromatographic analyses of follicle-stimulating hormone in human serum. (1981) (19)
DETECTION OF PENICILLIN ALLERGY BY RADIOALLERGOSORBENT TEST (1979) (19)
Platelet and plasma catecholamines in relation to plasma minerals and parathyroid hormone following acute myocardial infarction. (1990) (19)
A comparison between chorionic gonadotrophins extracted from human, rhesus monkey and marmoset placentae. (1972) (19)
Treatment with active vitamin D (alphacalcidol) in patients with mild primary hyperparathyroidism. (1989) (18)
Serum ferritin levels in male blood donors: relation to number of phlebotomies and iron supplementation. (1978) (18)
TRH tests with analyses of TSH, prolactin, and GH responses in subtypes of patients with major depressive disorders (1986) (18)
Treatment of malignant endocrine pancreatic tumors with a new long-acting somatostatin analogue, SMS 201-995. (1988) (18)
The early serum insulin response to intravenous glucose in patients with decreased glucose tolerance and in subjects with a familial history of diabetes mellitus. (1976) (18)
Studies on allergens of horse epithelium with two variants of RAST. (1974) (18)
The similarity of chorionic gonadotrophin and its subunits in term placentae from man, apes, old and New World monkeys and a prosimian. (1981) (18)
Peptide contraception in women. Inhibition of ovulation by chronic intranasal LRH agonist therapy. (1985) (18)
EFFECTS OF OESTROGEN ON SERUM LEVELS OF LH AND FSH (1970) (18)
Anemia of chronic inflammatory arthritides: treatment with recombinant human erythropoietin. (1991) (18)
Effects of continuous daily administration of 0.1 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogens. (1970) (17)
Growth hormone treatment affects brain neurotransmitters and thyroxine [see comment]. (1996) (17)
Effects of continuous daily administration of 0.5 mg of chlormadinone acetate on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogens. (1970) (17)
Postovulatory contraception in women with large doses of norethindrone. (1972) (17)
FAILURE OF POSITIVE FEEDBACK OF OESTRADIOL DURING CHRONIC INTRANASAL LUTEINIZING HORMONE‐RELEASING HORMONE AGONIST TREATMENT (1982) (16)
Chorionic Gonadotropin in Rodents (1980) (16)
Diagnosis of Pregnancy in Mares by an Immunological Method (1963) (16)
Maternal and gestational correlates of pregnancy prolactin and growth hormone in USA and China (2003) (16)
Endocrine Changes Before and After the Menarche (1975) (16)
Determination of fibrinogen and fibrinolysis products in human plasma by an immunochemical method. (1965) (16)
A stimulation test with calcitonin for differential diagnosis of hypercalcaemia. (1984) (16)
Serum growth hormone in patients with carcinoid tumours; basal levels and response to glucose and thyrotrophin releasing hormone. (1985) (16)
The effect of apomorphine on basal and TRH stimulated release of thyrotrophin and prolactin in man. (1975) (16)
Relationship between corpora lutea or fetal number and plasma concentrations of progesterone and testosterone in mice. (1985) (15)
Serum electrolytes and parathyroid hormone concentrations in acute myocardial infarction. (2009) (15)
Human gonadotropin therapy. I. Serum estradiol and progesterone patterns during conceptual cycles. (1983) (15)
The insulin tolerance test after pre-treatment with dexamethasone. (1976) (15)
L-asparaginase and prednisolone pretreatment followed by rubidomycin and cytosine arabinoside for induction of remission in adult patients with acute myeloblastic leukaemia. (2009) (15)
Indices of mineral metabolism in relation to blood pressure in a sample of a healthy population. (2009) (15)
Quality requirements of basal S-TSH assays in prediction an S-TSH response to TRH. (1980) (14)
Human pituitary thyrotropin Isolation of α and β subunits by hydrophobic interaction chromatography (1978) (14)
Bromocriptine-induced regression of a suprasellar extending prolactinoma during pregnancy (1984) (14)
Changes in calcium metabolic indices during long-term treatment of patients with essential hypertension. (1988) (14)
CIMETIDINE IN PRIMARY HYPERPARATHYROIDISM (1980) (14)
Studies on antibody formation in patients treated with L-asparaginase. (1970) (14)
BROMOCRIPTINE TREATMENT OF SEVEN WOMEN WITH PRIMARY AMENORRHOEA AND PROLACTIN‐SECRETING PITUITARY TUMOURS (1979) (13)
Gonadotrophin in the term placenta of the dolphin (Tursiops truncatus), the Californian sea lion (Zalophus californianus), the grey seal (Halichoerus grypus) and man. (1986) (13)
A RAST neutralization test for detection of blocking antibodies in serum after hyposensitization. (1976) (13)
Acute effects of ethanol intake on the serum concentrations of parathyroid hormone, calcium and phosphate. (2009) (13)
The contraceptive efficacy of 10 mg or 25 mg of norethindrone given orally on day 15–22 of the human menstrual cycle (1974) (13)
Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH. (1976) (13)
Immunological and biological activity of human chorionic gonadotrophin in urine and serum of pregnant women and women with a hydatidiform mole. (1967) (13)
Effects of oestrogen on serum levels of LH and FSH. (1971) (12)
The site of progesterone production in early pregnancy. (1972) (12)
Stability studies on human pituitary prolactin. (1985) (12)
The Response to TRH, LH‐RH, Metyrapone and Vasopressin in Patients with Hypothalamo‐Pituitary Disorders (1973) (12)
Physiological response to phlebotomies for autologous transfusion at elective hip‐joint surgery (1991) (12)
Influence of LH/FSH releasing hormone (LRH) on the basal secretion of gonadotrophins in relation to plasma levels of oestradiol, progesterone and prolactin during the post-partum period in lactating and in non-lactating women. (1977) (12)
Serum ferritin during infection. A longitudinal study in renal transplant patients. (2009) (12)
A New Principle Suggested for Detection of Darbepoetin-α (NESP) Doping (2003) (12)
NEW METHOD FOR DIAGNOSIS OF HYDATIDIFORM MOLE. (1964) (12)
Serum electrolytes and parathyroid hormone in patients in a coronary care unit (1989) (12)
DYNAMIC TESTS OF PARATHYROID FUNCTION FOR DIAGNOSIS OF PRIMARY HYPERPARATHYROIDISM IN MALIGNANCY (1987) (12)
Serum eythropoietin in athletes at moderate altitude (1992) (12)
Effects of beta-adrenergic blockade on serum parathyroid hormone in normal subjects and patients with primary hyperparathyroidism. (2009) (11)
Molecular size and charge as dimensions to identify and characterize circulating glycoforms of human FSH, LH and TSH (2017) (11)
MEDICAL EXPERIENCE IN ENZYME PRODUCTION (1973) (11)
Effects on serum parathyroid hormone of intravenous treatment with alphacalcidol in patients on chronic hemodialysis. (1990) (11)
An immunological cross reaction between monkey gonadotrophin preparations and antisera to human gonadotrophins. (1971) (11)
Serum growth hormone and gonadotrophins and urinary steroids in adolescent girls. (1975) (11)
THE IMMUNOLOGICAL AND BIOLOGICAL ACTIVITY OF HUMAN CHORIONIC GONADOTROPHIN IN URINE. (1964) (11)
[13] Use of particulate immunosorbents in radioimmunoassay (1981) (11)
Erythropoietin concentrations and isoforms in urine of anonymous Olympic athletes during the Nagano Olympic Games (2002) (11)
SERUM ERYTHROPOIETIN FOLLOWING CYTOSTATIC THERAPY (1990) (11)
Effects of prolonged luteinizing hormone-releasing hormone therapy on follicular maturation, ovulation and corpus luteum function in amenorrhoeic women with anorexia nervosa. (1979) (11)
Immunoelectrophoretic Studies on Purified Human Growth Hormone (1960) (10)
The plasma prolactin levels in man during prolongation of darkness in the morning. (1975) (10)
Bromocriptine therapy in eleven patients with acromegaly. (1978) (10)
Letter: Serum thyrotrophin and lipid levels in summer and winter. (1973) (10)
Gonadotrophic activity of the guinea-pig placenta during pregnancy. (1982) (10)
Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men. (1980) (10)
Localization of mRNA for the beta-subunit of placental hCG by in situ hybridization. (1988) (10)
Precipitation of 125I-labelled IgG aggregates by factors in sera of healthy individuals and of patients with rheumatoid arthritis. (1977) (10)
Inventions Leading to the Development of the Diagnostic Test Kit Industry – From the Modern Pregnancy Test to the Sandwich Assays (2005) (10)
Human pituitary thyrotropin. Characterization of five glycoproteins with thyrotropin activity. (1977) (10)
Superagonists of LHRH for contraception in women (1984) (10)
Chronic effects of the stimulatory luteinizing hormone-releasing hormone analogue D-Ser (TBU) 6-EA 10-LRH on the gonadotrophin and gonadal steroid secretion in women with amenorrhoea. (1980) (9)
Evaluation of parathyroid function in patients with hypergastrinaemia and pernicious anaemia. (1982) (9)
Vasopressin test in tumours of the sellar region. (1969) (9)
Effects of propranolol and verapamil on plasma ionized calcium and parathyroid hormone in short-term intense isokinetic leg exercise. (1988) (9)
Induction of male puberty by long-term pulsatile subcutaneous LH-RH therapy. (1984) (9)
TRIIODOTHYRONINE INTOXICATION (1979) (8)
Phosphate metabolism in renal stone formers. (II): Relation to renal tubular functions and calcium metabolism. (1981) (8)
Human chorionic gonadotrophin excretion in men and women with invasive trophoblast assayed by an immunological and a biological method. (1968) (8)
Insulin-induced hypoglycaemia stimulates secretion of parathyroid hormone. (2009) (8)
Large somatostatin-insensitive thyrotrophin-secreting pituitary tumour responsive to D-thyroxine and dopamine agonists. (1993) (8)
Thyroid function in breast cancer patients before and up to two years after mastectomy. (1979) (8)
Reduction of serum parathyroid hormone levels during sympathetic stimulation in man (1987) (8)
Plasma testosterone levels and urinary (LH) excretion following surgical trauma in man (1968) (8)
Effects of 1,25- and 24,25-dihydroxycholecalciferol on parathyroid hormone release from human parathyroid cells in vitro. (1984) (8)
Interactions between indices of calcium metabolism and blood pressure during calcium infusion in humans. (1989) (8)
Regulation of iron therapy by S-ferritin estimations in patients on chronic hemodialysis. (1981) (8)
Subcutaneous pulsatile LH-RH therapy of secondary amenorrhoea. (1984) (8)
Effect of short‐term and intermittent normobaric hypoxia on endogenous erythropoietin isoforms (2003) (8)
Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumors. (1978) (8)
Dynamics of parathyroid hormone release and serum calcium regulation after surgery for primary hyperparathyroidism (1992) (7)
Secondary hyperparathyroidism in diabetic and nondiabetic patients on long-term continuous ambulatory peritoneal dialysis (CAPD). (1985) (7)
Spontaneous variations in renal vein renin activity in man. (1982) (7)
Relationship of the sex of the foetus to the amount of human chorionic gonadotrophin in placentae; single and dizygotic twin placentae compared. (1975) (7)
Aspects of thyroid function during use of Norplant implants. (1986) (7)
Postconceptional fertility control by prostaglandins. (1973) (7)
Hypergonadotropic hypogonadism in oligophrenia. (2009) (7)
EFFECTS OF DAILY ADMINISTRATION OF A RETROSTEROID ON THE PLASMA LEVELS OF PROGESTERONE AND ON THE URINARY EXCRETION OF LUTEINIZING HORMONE AND TOTAL OESTROGENS (1970) (7)
Effects of 17β-oestradiol and norethisterone acetate on sulfonation and sialylation of gonadotrophins in post-menopausal women (2010) (7)
Acute effects of a new stimulatory luteinizing hormone-releasing hormone analogue D-Ser(TBU)(6)-EA(10)-LRH on the gonadotrophin and gonadal steroid secretion in women with amenorrhoea. (1977) (6)
Serum Levels of FSH and LH Following Normal Parturition (1973) (6)
Treatment with cimetidine in patients with primary hyperparathyroidism. (1982) (6)
Purification and characterization of high molecular weight human pituitary prolactin. (1981) (6)
A system for in vitro monitoring of occupational sensitization of workers in bioindustrial plants (1995) (6)
Effects of secretin on parathyroid hormone and calcium in normal subjects, patients with hyperparathyroidism and patients with gastrinoma. (2009) (6)
CEREBROSPINAL FLUID FERRITIN IN NEWBORN INFANTS (1982) (6)
High frequency of in situ hybridization on thin plastic sections of human placenta with a cDNA probe for beta hCG. (1989) (6)
IMMUNOLOGICAL DETERMINATION OF PITUITARY LUTEINIZING HORMONE IN THE URINE OF FERTILE AND POST-MENOPAUSAL WOMEN AND ADULT MEN (1962) (6)
Isoforms of human gonadotrophins under different physiological conditions (1997) (6)
Nocturnal secretory patterns of FSH, GH, LH and TSH. (1974) (5)
Ambulatory morning growth hormone concentrations increase in men and decrease in women with age (2002) (5)
Upsala Journal of Medical Sciences (2015) (5)
Calcium metabolic indices, vascular retinopathy, and plasma renin activity in essential hypertension. (1990) (5)
A new principle suggested for detection of darbepoetin-alpha (NESP) doping. (2003) (5)
PRICK‐ AND RADIOALLERGSORBENT TESTS (RAST) TO ALCALASE® IN A POPULATION NOT EXPOSED TO ENZYME DETERGENTS (1976) (5)
Treatment of malignant endocrine pancreatic tumors with a new long-acting somatostatin analogue, SMS 201–995 (1987) (5)
The long-acting dopamine agonist pergolide mesylate for treatment of hyperprolactinaemia. (1984) (5)
The effect of synthetic luteinizing hormone-releasing hormone on blood levels of luteinizing hormone and follicle stimulating hormone in Klinefelter patients. (1973) (5)
Parathyroid autotransplantation. An investigation of parathyroid autograft function. (1983) (5)
Calcium metabolism and arterial blood pressure in a healthy population sample and in hypertensive men. (1986) (4)
Serumpituitary andsexsteroid hormone levels intheetiology ofprostatic cancer a population-based case-control study (1993) (4)
Transsphenoidal therapeutic puncture of a cystic pituitary adenoma. (1987) (4)
Serum concentrations of parathyroid hormone in euparathyroid subjects during cimetidine treatment. (1980) (4)
Progesterone-induced augmentation of pituitary gonadotrophin responses to luteinizing hormone-releasing hormone in oestrogen-pre-treated amenorrhoeic women. (1976) (4)
Unique pattern of N-glycosylation, sialylation and sulfonation on TSH molecules in serum of children up to 18 months. (2019) (4)
The radioallergosorbent test used for characterization of allergenic extracts. (1973) (4)
Quantitative determination of albumin in normal urine by an immunochemical method. (1963) (4)
An association between mineral metabolism and the renin-aldosterone system in human hypertension. (1989) (4)
The effect of splanchnic block on renin production and renal haemodynamics in hypertensive patients. (1979) (3)
[The value of RASt in the diagnosis of allergic asthma and rhinitis]. (1972) (3)
Vasopressin test in cases of optic atrophy and optic neuritis (1971) (3)
Urinary albumin/total protein ratio in toxemia of pregnancy. (1963) (3)
Effect of salbutamol, a beta‐2‐adrenergic agonist, on erythropoietin concentration in healthy males (2002) (3)
Human pituitary thyrotropin. Isolation and recombination of subunit isoforms. (1980) (3)
URINARY EXCRETION OF INTERSTITIAL CELL STIMULATING HORMONE AND SPERM CONCENTRATION IN 219 MALES (1969) (3)
Median charge of gonadotrophin isoforms in the pituitary gland and in the circulation of sheep fetuses from mid- to late gestation. (1996) (3)
An endocrinological study of the puberty. (1971) (3)
Long-term subcutaneous pulsatile low dose LH-RH administration for treatment of infertile men with secondary hypogonadotrophic hypogonadism. (1984) (3)
Clinical studies on phosphate handling in hypercalcaemia. (2009) (3)
PINEAL GLAND, F.S.H., AND BREAST-CANCER ÆTIOLOGY (1978) (3)
15th Annual Meeting of ISGD (1989) (2)
Improved differential diagnosis of hypercalcemia by hypocalcemic stimulation of parathyroid hormone secretion (1988) (2)
HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone). (1981) (2)
Parathyroid hormone and osteocalcin levels in plasma and ultrafiltrate during hemofiltration. (1993) (2)
Serial measurements of plasma renin activity, aldosterone and cortisol during percutaneous transluminal angioplasty of the renal artery in man. (1988) (2)
EFFECTS OF OESTROGEN ON SERUM LEVELS (2008) (2)
Comparison between serum levels of oestriol in venous and capillary blood from pregnant women. (1982) (2)
The effect of splanchnic block on renal haemodynamics and renin production in hypertensive patients. (2009) (2)
The response to TRH, LH-RH, metyrapone and vasopressin in patients with hypothalamo-pituitary disorders. (1973) (2)
THE PITUITARY RESPONSIVENESS TO LH‐RELEASING HORMONE IN ANOREXIA NERVOSA (1975) (2)
Effects of acute intravenous injection of two growth hormone-releasing hormones (GHRH 1-40 and 1-29) on serum growth hormone and other pituitary hormones in short children with pulsatile growth hormone secretion. (1989) (2)
Phosphate Treatment of Calcium Urolithiasis (1985) (2)
Levels of Somatomedin-Binding Protein in Amniotic Fluid from Pregnancies with Small and Large for Gestational Age Infants (1987) (2)
Thyrotropin N-glycosylation and Glycan Composition in Severe Primary Hypothyroidism (2021) (2)
PITUITARY RESPONSIVENESS TO LUTEINIZING HORMONE‐RELEASING HORMONE DURING TREATMENT WITH SUBDERMAL D‐NORGESTREL IMPLANTS IN WOMEN (1979) (2)
GONADOTROPHIN-RELEASING HORMONE TREATMENT FOR INDUCTION OF FOLLICULAR MATURATION AND OVULATION IN AMENORRHOEIC WOMEN WITH ANOREXIA NERVOSA (1976) (2)
A solid phase radioimmunoassay for pancreatic glucagon. (1976) (1)
IMMUNOASSAY OF HUMAN PITUITARY LUTEINIZING HORMONE (1966) (1)
A new pituitary protein 7B2 is increased in patients with high alpha- or beta-hCG. (1989) (1)
LONG-TERM RESULTS OF CONTINUOUS LUTEINIZING HORMONE-RELEASING HORMONE (LRH) AGONIST TREATMENT FOR CONTRACEPTION IN WOMEN (1983) (1)
Serum-thyrotrophin and hypercholesterolaemia. (1973) (1)
Low- and Fully N-Glycosylated Gonadotropins Circulating in Women With Polycystic Ovary Syndrome (2021) (1)
Gender differences in sensitivity to short-term administration of growth hormone (GH) in healthy young adults (1998) (1)
Parathyroid function in relation to intestinal function and renal calcium reabsorption in patients with nephrolithiasis. (1992) (1)
Menstrual Function and Serum Prolactin Levels after Long-term Bromocriptine Treatment of Hyperprolactinaemic Amenorrhoea (1983) (1)
Human pituitary thyrotropin. Isolation of alpha and beta subunits by hydrophobic interaction chromatography. (1978) (1)
HCG-alpha and HCG-beta subunits as tumour markers during therapy in a case with so-called "non-functioning" islet cell tumour. (1981) (1)
Urinary excretion of interstitial cell stimulating hormone and sperm concentration in 219 males. (1970) (1)
[Results of some neuroendocrinological studies in patients with anatomically verified hypothalamic disorders]. (1974) (1)
The effects of long-term antithyroid drug treatment on serum reverse T3 in patients with Graves' disease. (2009) (1)
Rapid regression of pituitary tumours during bromocriptine treatment of women with hyperprolactinaemia. (1982) (1)
Gonadotropin Glycoforms Circulating in Women Using Progestins of the Levonorgestrel Family for Contraception (2020) (1)
Endocrine changes before and after the menarche. II. Serum levels of growth hormone and alkaline phosphatase, and urinary excretion of 17-ketosteroids and 17-hydroxycorticosteroids. (1975) (1)
An investigation of biochemical and radiographic signs of hyperparathyroidism in chronic renal disease. (1984) (1)
Values of intact serum parathyroid hormone in different stages of renal insufficiency. (1991) (1)
Serum levels of thyroid-stimulating hormone in hyperlipoproteinemia. (1975) (1)
Chronic Pulsatile Low Dose Luteinizing Hormone-Releasing Hormone Therapy (1983) (1)
HCG‐α and HCG‐β Subunits as Tumour Markers during Therapy in a Case with So‐Called “Non‐Functioning” Islet Cell Tumour (2009) (1)
Increase of plasma renin activity at renal blood flow estimations with the xenon133 wash-out technique in patients with renal artery stenosis. (1987) (1)
Comparison between Serum Levels of Oestriol in Venous and Capillary Blood from Pregnant Women (1982) (0)
Determination of fibrinolytic split products in serum and urine in 1.001 pregnant women (1970) (0)
Contents, Vol. 31, 1989 (1989) (0)
Immunocytochemical, chemical and nuclear-DNA studies of pituitary tumours (1970) (0)
EFFECTS OF DAILY LUTEAL PHASE ADMINISTRATION OF AN LRH AGONIST ON THE GONADOTROPHIN AND PROGESTERONE SECRETION IN WOMEN (1983) (0)
EFFECTS OF SALBUTAMOL ON ENDOGENOUS ERYTHROPOIETIN CONCENTRATION (2002) (0)
Subject Index, Vol. 31, 1989 (1989) (0)
A RADIO-IMMUNOSORBENT ASSAY FOR PROTEIN HORMONES (1967) (0)
Plasma Progesterone and 17α-hydroxyprogesterone measured by a Competitive Protein Binding Technique and related to the Oestrogen Excretion and LH Level around Ovulation in the normal Menstrual Cycle (1971) (0)
Subject Index, Vol. 55, 1990 (1990) (0)
Precipitation of1251-labelled IgGaggregates byfactors inseraofhealthy individuals andofpatients with rheumatoid arthritis (1977) (0)
MORPHOLOGICAL AND CHEMICAL DIAGNOSIS OF PITUITARY TUMORS: (1982) (0)
Subject Index, Vol. 6 (Suppl. 1), 1986 (1986) (0)
Surgery for primary hyperparathyroidism-long term effects on serum calcium and intact parathyroid hormone, values (1992) (0)
Vasopressin test incasesofoptic atrophy and optic neuritis (1971) (0)
Contents, Vol. 48, 1988 (1975) (0)
Contents, Vol. 52, 1976 (1976) (0)
Pineal gland F.S.H. and breast-cancer aetiology. (Letter). (1978) (0)
Precipitation of 1251labelled 1251labelled 1251labelled IgG aggregates by factors in sera of healthy individuals and of patients with rheumatoid arthritis (0)
Principles, technical difficulties and developments of radioimmunoassay procedures (1979) (0)
[Peptide-producing tumors in the pancreas and gastrointestinal tract: syndrome, survey, therapy]. (1984) (0)
[Hormonal patterns in different types of abnormal menstrual cycles]. (1970) (0)
Reaginic bronchial allergy and the occurrence of reagins against mites in a representative sample of a local Swedish population. (1975) (0)
[Current status of thyroid function diagnosis]. (1976) (0)
38 Interrelationships between changes in calcium metabolic indices and blood pressure during calcium infusion in humans (1988) (0)
Pulsatile subcutaneous LHRH treatment of hypogonadotropic hypogonadism in the human (1984) (0)
91158366 Skeletal responsiveness to parathyroid hormone in healthy females: Relationship to menopause and oestrogen replacement (1991) (0)
ESTROGEN EFFECTS ON SERUM GONADOTROPHINS (1969) (0)
INTRANASAL ADMINISTRATION OF LH‐RELEASING HORMONE (1975) (0)
EFFECTS OF CONTINUOUS DAILY ADMINISTRATION OF 0.5 MG OF NORETHINDRONE ON THE PLASMA-PROGESTERONE LEVEL AND THE URINARY EXCRETION OF LUTEINIZING HORMONE, PREGNANEDIOL AND TOTAL OESTROGENS (1969) (0)
Effects of Bromocriptine-induced Pregnancy on Prolactin-secreting Pituitary Tumours (1982) (0)
The heterogeneity of follicle-stimulating hormone (1988) (0)
Determination of Half-lives of Circulating FSH and LH Glycoforms in Women During GnRH Receptor Blockade (2022) (0)
Contents, Vol. 55, 1990 (1990) (0)
363 Production of PP and HCG-a in lung-carcinoids with the carcinoid syndrome (1983) (0)
IMMUNOLOGICAL DETERMINATION OF PITUITARY LUTEINIZING HORMONE IN THE URINE OF NORMAL WOMEN (1962) (0)
RIEPILOG ON GONADOTROPINS (1966) (0)
The contraceptive efficacy of 10mg or 25mg of norethindrone given orally on day 15-22 of the human menstrual cycle. (1974) (0)
Determination of Gonadotropins in Urine by a Haemagglutination Inhibition Reaction (2008) (0)
Early detection of endocrine pancreatic tumors in men-1 — a clinical benefit of a standardized meal stimulatory test (1987) (0)
Inhibition of ovulation in women by chronic treatment with a stimulatory LRH analogue - a new approach to birth control? (1978) (0)
FSH and LH heterogeneity during GnRH-agonist treatment (1996) (0)
INCREASED LH SECRETION FOLLOWING ADMINISTRATION OF OESTRADIOL (1971) (0)
INDUCTION OF A MIDCYCLE-LIKE PEAK OF LUTEINIZING HORMONE IN YOUNG WOMEN BY EXOGENOUS OESTRADIOL-17β (1972) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Leif Wide?

Leif Wide is affiliated with the following schools:

Leif Wide's Academic­Influence.com Rankings

Why Is Leif Wide Influential?

Leif Wide's Published Works

Published Works

What Schools Are Affiliated With Leif Wide?

Leif Wide's AcademicInfluence.com Rankings